PHC003
A 5000 patient Monte Carlo simulations, based on previous population PK data from ICU patients 1 and creatinine clearance (CLcr): 80 mL/min, 40 mL/min and 20 mL/min, were performed to predict steady-state concentration (C SS )time profiles (NONMEM v.6) .
Typical adult doses of MEP (MEP 1g IV q6h-q8h-q12h) were simulated as 0.5h, 1h, 2h and 3h extended IV infusions (EI).
A range of MICs was studied, S: ≤ 2 mg/L, I: 4 mg/L and R: > 8 mg/L, according to the EUCAST cut-off 2 for P. aeruginosa to MEP.
The likelihood of target attainment (PTA 50 : fT SS >MIC > 50%), was calculated (SPlus 6.1) for each EI while keeping the interdose interval of 6h, 8h or 12h. A PTA 50 value > 90% was considered satisfactory.
RESULTS:
In patients with CLcr around 80 mL/min: High doses of MEP: 1g IV for 30 min/6h were needed to reach PTA 50 > 90%) for MICs ≤ 2 mg/L. For higher MICs, even this dose was clearly inadequate. (Fig.1 PTA 50 remained above 90% whilst Clcr = 40 mL/min, for the usual regimens (1g/6h or 8h 30 min) and MICs ≤ 2 mg/L. (Fig.3) When Clcr = 20 mL/min, MEP 1g IV/12h reached PTA 50 values slightly below or above 90% for MIC = 4 mg/L, despite infusion length. (Fig.4 
CONCLUSIONS:
The probability of attaining PTA 50 for a given MIC rises as long as the infusion time increases.
The length of infusion has less impact on PTA 50 in patients with moderate/severe renal impairment.
MEP administered as an extended infusion of 3h might increase the likelihood of microbiological eradication and clinical outcome in ICU patients and high MICs for P. aeruginosa.
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